1 / 12

What is a QALY worth? Admissible utility functions for health, longevity & wealth

What is a QALY worth? Admissible utility functions for health, longevity & wealth. James K. Hammitt Harvard University (Center for Risk Analysis) Toulouse School of Economics (LERNA-INRA). Standard metrics for valuing health . Willingness to pay (WTP)

tori
Download Presentation

What is a QALY worth? Admissible utility functions for health, longevity & wealth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. What is a QALY worth? Admissible utility functions for health, longevity & wealth James K. Hammitt Harvard University (Center for Risk Analysis) Toulouse School of Economics (LERNA-INRA)

  2. Standard metrics for valuing health • Willingness to pay (WTP) • Widely used in environmental & transportation applications • Quality-adjusted life years (QALYs) • Widely used in public health and medical applications • DALYs (disability-adjusted) • Utility for health and wealth • What utility functions are consistent with both concepts? • Implications for WTP to reduce health risk

  3. Louis’ contribution • U(w, h) • U1 > 0, U2 > 0 • U11 < 0, U22 < 0 • U12 ≥ 0 • Bleichrodt, Crainich, Eeckhoudt, ‘Comorbidities and the willingness to pay for health improvements’, J Public Econ 2003

  4. Quality-adjusted life years • Sum of duration-weighted “health-related quality of life” • q(h) = HRQL • T = duration • v(∙) usually linear or present value • Neglect non-health consequences • What is ‘health’ (h)? • Includes ‘self-care’ & ‘usual activities’?

  5. QALYs • Strong assumptions about preferences • 1. Constant proportional tradeoff of duration for health • HRQL independent of duration, consumption, & other factors • 2. Risk preference for duration independent of health • Can be generalized

  6. Willingness to pay • Compensating variation • Change in money (that can be used for any purpose) that exactly offsets change in health risk • Weak assumptions • More money is better • Non-satiation (local)

  7. Admissible utility functions • Assume (for any level of wealth) • Preferences for health and longevity are consistent with QALYs • Q(h, T) = v[q(h), T] • q(h) independent of w • Then (future) lifetime utility • u(h, T, w) = [Q(h, T)] a(w) + b(w) • a(w) > 0

  8. u(h, T, w) = [Q(h, T)] a(w) + b(w) Marginal utility of wealth • b' ≥ 0 (standard, marginal utility of bequest) • a' > 0 ↔ marginal utility of wealth greater if alive than dead (standard) • → marginal utility of wealth increasing with • Health (standard?) • Longevity (highly plausible) • →

  9. u(h, T, w) = [Q(h , T)] a(w) + b(w) Marginal WTP per QALY (m) Marginal value of QALY Effect of health & longevity on wealth (neglect) • mis independent of Q (future health & longevity) iff a' = 0 • → marginal utility of wealth independent of survival, health, & longevity • a' > 0 →mdecreases with Q • Diminishing marginal WTP with severity & duration of potential illness • WTP increases with age and chronic/future illness

  10. Value per statistical life ua = utility if survive period ud= utility if die (bequest) ua > udua' > ud' ≥ 0 Drèze, ‘L’utilité sociale d’une vie humaine’, Revue Française de Recherche Opérationnelle1962

  11. QALYs and VSL Utility if survive Utility of bequest b'(w) = 0 → VSL is independent of QALYs b'(w) > 0 → VSL increases with QALYs, but less than proportionately

  12. Implications • WTP per QALY not constant • Decreases with future QALYs • Value of reducing morbidity risk not proportional to expected QALY gain • VSL not proportional to future QALYs • Decreases with future QALYs • VSL independent of QALYs if indifferent to bequest (b' = 0) • Value of reducing mortality risk not proportional to expected QALY (or life expectancy) gain

More Related